The Committee of Experts on the Classification of Medicines as Regards their Supply (CD-P-PH/PHO), co-ordinated by the European Directorate for the Quality of Medicines & HealthCare (EDQM), has just published five new evidence-based classification reviews (EBRs) on herbal medicines. These reviews, drafted in 2025, concern:
- castor oil (Ricinus oleum);
- St John’s wort (Hypericum herba);
- capsicum (Capsicum);
- ivy leaf (Hedera helix folium);
- agnus castus fruit (Agni casti fructus).
The CD-P-PH/PHO adopted a new format for EBRs following the roll-out of the recently developed assessment approach described in the recently published Guidelines on key considerations in issuing recommendations on the classification of active substances as regards their supply (prescription and non-prescription status).
All EBRs are published on the CD-P-PH/PHO Programme results web page, maintained by the EDQM. More information is available on the Classification of medicines web page.
See also: